Jean is focused on pulmonary vascular disease, and she is very active in clinical trials in the pulmonary hypertension space. It is a very exciting time for pulmonary vascular disease research, as they are looking at novel pathways and new ways to use existing medications to better outcomes for their pulmonary arterial hypertension patients. They are making great progress and have been able to impact their patients’ lives in a positive way through ongoing efforts to better understand this disease process and develop medications for this condition.